• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

miR-193b represses influenza A virus infection by inhibiting Wnt/β-catenin signaling

tetano

Editor, Senior Moderator
Cell Microbiol. 2019 Jan 16:e13001. doi: 10.1111/cmi.13001. [Epub ahead of print]
[h=1]miR-193b represses influenza A virus infection by inhibiting Wnt/β-catenin signaling.[/h] Yang X[SUP]1,[/SUP][SUP]2[/SUP], Zhao C[SUP]2[/SUP], Bamunuarachchi G[SUP]1,[/SUP][SUP]2[/SUP], Wang Y[SUP]2[/SUP], Liang Y[SUP]1,[/SUP][SUP]2[/SUP], Huang C[SUP]1,[/SUP][SUP]2[/SUP], Zhu Z[SUP]1,[/SUP][SUP]2[/SUP], Xu D[SUP]1,[/SUP][SUP]2[/SUP], Lin K[SUP]1,[/SUP][SUP]2[/SUP], Senavirathna LK[SUP]1,[/SUP][SUP]2[/SUP], Xu L[SUP]2[/SUP], Liu L[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Due to an increasing emergence of new and drug-resistant strains of the influenza A virus (IAV), developing novel measures to combat influenza is necessary. We have previously shown that inhibiting Wnt/β-catenin pathway reduces IAV infection. In this study, we aimed to identify antiviral human microRNAs (miRNAs) that target the Wnt/β-catenin signaling pathway. Using a miRNA expression library, we identified 85 miRNAs that upregulated and 20 miRNAs that downregulated the Wnt/β-catenin signaling pathway. Fifteen miRNAs were validated to upregulate and 5 miRNAs to downregulate the pathway. Overexpression of 4 selected miRNAs (miR-193b, miR-548f-1, miR-1-1 and miR-509-1) that downregulated the Wnt/β-catenin signaling pathway reduced viral mRNA, protein levels in A/PR/8/34-infected HEK293 cells and progeny virus production. Overexpression of miR-193b in lung epithelial A549 cells also resulted in decreases of A/PR/8/34 infection. Furthermore, miR-193b inhibited the replication of various strains, including H1N1 (A/PR/8/34, A/WSN/33, A/Oklahoma/3052/09) and H3N2 (A/Oklahoma/309/2006), as determined by a viral reporter luciferase assay. Further studies revealed that β-catenin was a target of miR-193b and β-catenin rescued miR-193b-mediated suppression of IAV infection. miR-193b induced G0/G1 cell cycle arrest and delayed vRNP nuclear import. Finally, adenovirus-mediated gene transfer of miR-193b to the lung reduced viral load in mice challenged by a sublethal dose of A/PR/8/34. Collectively, our findings suggest that miR-193b represses IAV infection by inhibiting Wnt/β-catenin signaling.
This article is protected by copyright. All rights reserved.


PMID: 30650225 DOI: 10.1111/cmi.13001
 
Back
Top Bottom